These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9711401)

  • 41. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth factors of the future.
    Nemunaitis J
    Leuk Lymphoma; 1993 Mar; 9(4-5):329-36. PubMed ID: 8348068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy.
    James G
    Rev Invest Clin; 1990 Jul; 42 Suppl():22-7. PubMed ID: 19256128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunostimulating drugs and cytokines].
    Lehners N; Goldschmidt H; Raab MS
    Ther Umsch; 2011 Nov; 68(11):655-8. PubMed ID: 22045528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistology of skin and oral biopsies in graft-versus-host disease after bone marrow transplantation and cytokine therapy.
    Yamada H; Chihara J; Hamada K; Matsukura M; Yudate T; Maeda K; Tubaki K; Tezuka T
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S73-6. PubMed ID: 9440549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1997; 17():287-315. PubMed ID: 9551217
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 49. [Macrophage-colony stimulating factor (M-CSF) and its use in clinical practice].
    Groblewska M; Mroczko B; Szmitkowski M
    Pol Arch Med Wewn; 2004 Mar; 111(3):355-65. PubMed ID: 15230219
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical application of hematopoietic growth factor (IL-3, G-CSF, GM-CSF, and EPO)].
    Motoyoshi K
    Nihon Rinsho; 1992 Aug; 50(8):1967-72. PubMed ID: 1279240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hematopoietic growth factors in the limelight. New actors on the pharmacotherapeutic stage].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):407-9. PubMed ID: 1708442
    [No Abstract]   [Full Text] [Related]  

  • 52. Hematopoietic growth factors: overview and clinical applications, Part III.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Nov; 300(5):311-21. PubMed ID: 1700606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cytokines in the treatment of blood diseases].
    Robak T
    Acta Haematol Pol; 1995; 26(2 Suppl 1):72-8. PubMed ID: 7544526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interactive discussion on chemotherapy-related adverse events.
    Adams VR; Lyman GH
    Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
    [No Abstract]   [Full Text] [Related]  

  • 56. The role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in chemotherapy for lung cancer.
    Saijo N; Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):54-8. PubMed ID: 7512277
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytokines as therapeutic drugs.
    Schooltink H; Rose-John S
    J Interferon Cytokine Res; 2002 May; 22(5):505-16. PubMed ID: 12060489
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological monitoring and clinical trials of biological response modifiers.
    Kopp WC; Holmlund JT; Urba WJ
    Cancer Chemother Biol Response Modif; 1994; 15():226-86. PubMed ID: 7540029
    [No Abstract]   [Full Text] [Related]  

  • 59. Granulocyte and granulocyte-macrophage colony-stimulating factors.
    Laplanche A
    Lancet; 1993 Sep; 342(8872):678-9. PubMed ID: 7689678
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of granulocyte- and granulocyte-macrophage-colony-stimulating factors in the treatment of acute myeloid leukaemia.
    Johnson PR; Yin JA
    Br J Haematol; 1997 Apr; 97(1):1-8. PubMed ID: 9136935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.